Erythropoietins in cancer patients: ESMO recommendations for use.
Greil
R
R
Third Medical Department of Hematology, Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Paracelsus University Hospital Salzburg, Austria.
Thödtman
R
R
Roila
F
F
D000740:Anemia / Q000188:drug therapy* / Q000453:epidemiology; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D007501:Iron / Q000008:administration & dosage; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D015995:Prevalence; D013997:Time Factors
D004921:Erythropoietin; D007501:Iron